M. Clanet

Interferons and multiple sclerosis.

M. Clanet, P. Calvas, A. Blancher, 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

IL 2 RA and IL 7 RA genes confer susceptibility for multiple sclerosis in two independent European populations

F. Holsboer, G. Illei, E. Remmers, 2008 .

Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems.

M. Simonetta, O. Rascol, J. Montastruc, 1989, Brain : a journal of neurology.

Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases.

M. Clanet, S. Avrameas, B. Guilbert, 1988, Annales de l'Institut Pasteur. Immunology.

A prospective observational post‐marketing study of natalizumab‐treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

P. Vermersch, M. Clanet, B. Brochet, 2014, European journal of neurology.